News

By Priscila Mayumi Kashiwabara

New subject codes for filing applications for GMP certification for biological products industries

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good Manufacturing Practices certifications – GMP (“BPF” in Portuguese) for biological products industries.

Formerly, the protocol was carried out under subject codes related to Medicines – Sterile Products. In such scenario, the Brazilian FDA faced difficulties in monitoring the processes, and the procedures were more complex.

According to the Agency, the applicant is not required to make any changes to the petitions that have already been filed, as they will be regularly analyzed by the responsible department.

Find below the list of new subjects that must be used for new requests:

For more news and content related to ANVISA, please do not hesitate to contact us at: regulatorio@kasznarleonardos.com.

Back

Last by Priscila Mayumi Kashiwabara

14 de August de 2026

INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

Ler notícia

1 de July de 2026

INPI Ordinance No. 80/2026 and Second Medical Use Patents

INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination INPI Ordinance No. 80/2026 and Second Medical Use Patents

Ler notícia

29 de May de 2026

Kasznar Leonardos has been ranked by IAM Patent 1000

It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the Kasznar Leonardos has been ranked by IAM Patent 1000

Ler notícia